Background. Tuberculosis is a major public health problem in South Africa (Lancet 1998;352:1340-3) 
Directly observed therapy (DOT), and preferably short contained in the prespecified equivalence range of -20% to +20% and indicated zero rate difference. Male sex, course chemotherapy (DOTS), is one of the five key elements in the WHO global tuberculosis control prounemployment, and "new" patient status showed no difference in treatment success. Women, employed gramme strategy and has been widely publicised as a "breakthrough" and strongly promoted globally by the patients, and patients whose income derived from family or social support were more successful with self-WHO 1 2 and others. 3 The impetus for increasing DOT has largely been based on observational studies against supervised treatment but, although the upper limit of the equivalence interval was exceeded, favouring selfhistorical controls, with little or no randomised data of "head to head" DOT versus self-administered therapy.
supervision, the confidence interval included zero rate difference. Re-treatment patients, however, were sigThe Introductory Article by Zwarenstein et al is the first randomised trial of DOT against self-administered nificantly more successful with self-supervision than with DO (74% versus 42%; difference 32%, 90% CI therapy to compare adherence and outcome. 4 After random assignment of patients to direct observation 11 to 52), exceeding the 20% upper limit of equivalence and excluding zero difference. However, since only 60% (DO) or self-treatment with weekly checks of drug collection and use, the outcome measures (with cure or completed treatment in the self-treatment arm and a smaller proportion in the DO arm, a null effect of completed treatment regarded as a successful outcome) were compared on an intention to treat basis. Data for DOT cannot be concluded. The equivalence of the two methods could, however, be due to a failure of DOT the two sites combined showed treatment success, as defined, in 60% of self-supervised and 54% of DO itself to improve outcome or of more widespread resource and structural problems resulting in difficulties patients. The 6% difference (90% CI -5.1 to 17) was in supporting either type of care, since completion rates patient cooperation, and some in the USA have penal powers to deal with non-compliance. 21 were lower than in studies of DOT in other developing countries. 5 6 Systematic Cochrane-style reviews of all strategies across five trials-including patient reminders, superDevelopment of the concept of directly observed therapy (DOT) vision by health care workers, and cash incentives-had previously shown all to have positive effects on adWith the advent of chemotherapy in the 1950s it became clear that, not only was ambulatory treatment possible herence, 7 so the paper by Zwarenstein et al is the first randomised trial of specific antituberculosis compliance but, given the low availability of tuberculosis hospital beds in resource poor countries, it was the only realistic promoting strategies not to show a positive benefit of intervention.
option. Wallace Fox in an analysis of a Medical Research Council study 8 in Madras highlighted the problems of reaching high rates of treatment compliance in ambulatory patients. This led to the testing of DOT even in Compliance versus outcome Compliance with drug treatment in tuberculosis was such a resource poor environment and demonstrated that "long term daily supervised administration can be orrecognised as a problem in the 1950s. 8 Controlled trials with drug compliance measured by metabolite checks ganised under special circumstances, even in developing countries" 22 and, in turn, led to supervised intermittent have shown a significantly increasing trend to relapse with poor compliance. 9 Where the interrelationships treatment. 23 Moves towards supervised treatment were also tried in Hong Kong 24 and London. 25 26 between regimen, compliance, and relapse have been examined, compliance was the major determinant of In the USA selective DOT programmes were introduced in the early 1960s 27 but only for the "unreliable outcome (p<0.0001), but with age also being important. Relapse rates ranged from 1.1% in 731 patients with or questionably reliable individual". Sbarbaro then expanded the twice weekly supervised programme 28 and, good compliance, through 5.9% of 118 with moderate compliance, to 50% of 24 with poor compliance. 10 by the late 1970s, was advocating universally applied DOT.
29 30 Intermittent DOT continued to be advised Professor Fox's reviews of the practice of physicians and the compliance of patients 11 12 drew attention to the only for difficult patients 31 32 and was routinely practised only in some centres. 21 Only after the widespread system two elements involved: poor patient compliance with treatment and the administration of treatment for an failures of New York and its consequences was DOT made the standard of care as a matter of Federal policy. 33 excessive length of time.
Studies in England and Wales from 1978/9, 13 through Since some physicians still felt that universal DOT was unnecessary where other approaches had proved the 1980s 14 15 and in 1993 16 have consistently shown that treatment is given for longer than required in either effective, a compromise dictated that universal DOT was not required where "a qualitative evaluation of local a majority or a significant minority of patients, which may encourage non-compliance in patients. treatment completion rates exceeded 90%".
33
In the UK selective DOT is advised for those thought likely or proved to be non-compliant. 17 However, whilst accepting that the UK health care system differed from Range of treatment options Short course chemotherapy is established as the "gold that of the USA, Morse also suggested in an editorial that universal DOT would become needed if rates of standard" treatment [17] [18] [19] [20] but there are a number of ways in which it can be given. Least satisfactory is adult non-completion were greater than 10% as reported in 1988.
15 unmonitored treatment where the patient is prescribed treatment without any subsequent form of assessment of compliance by a physician or nurse. Monitored selfmedication is where the compliance with the regimen Evidence for DOT Evidence supporting the use of DOT has mainly come is intermittently, preferably randomly, assessed by urine tests/pill counts; DOT is where all tablets should be from observational/comparative studies, often against historical cohort outcomes, and from cost effectiveness seen to be swallowed, and can either be given selectively to those thought likely to be, or proven to be, nonanalysis either of decision analysis or modelling types, some of which are summarised in tables 1 and 2, compliant, or given unselectively or "universally". Many programmes of DOT have incentives built in to aid respectively. Many of the observational/comparative default from treatment. 21 Further comment was also chemotherapy made by the sceptics that a major reason for the success of the Bangladesh study 36 was implementation by "an effective non-governmental organisation capable of securing technical and financial support from several donor agencies". 52 studies have had additional programme elements which may have given the programme-including DOTEven in the USA there are dissenting analyses of the effectiveness of DOT. 53 This study estimated the DOT advantages over the previous programme with which it was being compared. These additional programme and treatment completion rates for the years 1990-4 for all tuberculosis treatment programmes in 25 cities elements can be important and contribute to the success of the programme independently from the DOT eleor counties with 100 cases in any year between 1990 and 1993 anywhere in the USA. Three cohorts were ment. A South African study 47 comparing the effectiveness of different types of DOT supervisor showed that formed: high treatment completion (>90%), intermediate completion (70-89%), and low completion treatment completion rates were better with community health workers (88%) or a voluntary lay person (85%) (<70%). In 1990 the median 12 month treatment completion rate was 80% for the entire study population, than with a clinic based health worker (79%), and also that the fall in case holding rates between 1991 and with a median estimated DOT rate of 16.8%. By 1994 those rates had increased to 87% and 49%, respectively, 1995 was less with community health workers (95% to 90%) and voluntary lay persons (88% to 84%) than with increases seen in all three completion rate cohorts. The authors conceded that DOT had had a marked with clinic based health workers (84% to 71%). A separate study, also in South Africa, showed that the impact in jurisdictions with historically low completion rates. They commented, however, that treatment comintroduction of dosage cards for DOT compliance increased the compliance from 62% to 88-93% after pletion rates of over 90% could be obtained with DOT proportions far lower than those proposed by advocates intervention. 48 Studies on the economic aspects of DOT are not of universal DOT, even though they admitted entering the study with the prejudice that more DOT was autowithout methodological criticism, often using historical or derived data on which the costs are modelled. A matically better. review of published cost effectiveness studies of tuberculosis treatment programmes 49 concluded that "those with fully ambulatory short course chemotherapy are Conclusions The Introductory Article 4 does not show any positive currently the most cost effective option, although this depends on the costs of providing an effective combenefit from the DOT intervention in the first direct comparison directly against self-administered treatment. munity based service. Whilst DOT may be more effective than self-administration because of the reduced need This does not mean that DOT is not effective as the problem could have been a weak programme. More for follow up and monitoring, more studies are needed, however, that include real outcome figures and housework needs to be done to define what are the most effective programme elements to support DOT, which hold measures of cost. Effects should be measured in terms of actual outcome and not taken from the litare most cost effective and useful in resource poor countries, with household or patient costs being erature. Most of the studies reviewed did not consider the difficulties of introducing a theoretically cost effectweighted more heavily. The USA analysis 53 shows that, in areas with historically low completion rates, these are ive change into a health service. Further work could consider measuring cost in terms of resources-for exsignificantly improved; equally, high completion rates (>90%) can be achieved with only modest rates of ample, staff rather than only finances-and more work is needed on household perspectives".
DOT, and the cost benefits of further increasing the high completion rate in a good programme by a major increase in DOT may show this not to be a cost effective use of resources. The message may be that the inDissenting voices: disentangling the DOT element from other programme aspects vestment that DOT requires improves a weak programme by improving not just completion rates but Dissenters or sceptics who have labelled DOT as "supervised swallowing" 50 say that the success of DOT other programme elements, whereas universal or high 
